Szepesy, J.; Humli, V.; Farkas, J.; Miklya, I.; Tímár, J.; Tábi, T.; Gáborján, A.; Polony, G.; Szirmai, Á.; Tamás, L.;
et al. Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice. Int. J. Mol. Sci. 2021, 22, 2853.
https://doi.org/10.3390/ijms22062853
AMA Style
Szepesy J, Humli V, Farkas J, Miklya I, Tímár J, Tábi T, Gáborján A, Polony G, Szirmai Á, Tamás L,
et al. Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice. International Journal of Molecular Sciences. 2021; 22(6):2853.
https://doi.org/10.3390/ijms22062853
Chicago/Turabian Style
Szepesy, Judit, Viktória Humli, János Farkas, Ildikó Miklya, Júlia Tímár, Tamás Tábi, Anita Gáborján, Gábor Polony, Ágnes Szirmai, László Tamás,
and et al. 2021. "Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice" International Journal of Molecular Sciences 22, no. 6: 2853.
https://doi.org/10.3390/ijms22062853
APA Style
Szepesy, J., Humli, V., Farkas, J., Miklya, I., Tímár, J., Tábi, T., Gáborján, A., Polony, G., Szirmai, Á., Tamás, L., Köles, L., Vizi, E. S., & Zelles, T.
(2021). Chronic Oral Selegiline Treatment Mitigates Age-Related Hearing Loss in BALB/c Mice. International Journal of Molecular Sciences, 22(6), 2853.
https://doi.org/10.3390/ijms22062853